Skip to main content
    N

    Novartis AG ADR (NVS)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - GENERAL • NYSE

    $160.21
    -0.29 (-0.18%)

    Market Cap: $303.12B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Novartis AG ADR (NVS) Government Contracts

    Updated Aug 4, 2026. Contract data from federal award records.

    Federal agencies obligated $29.09M to Novartis AG ADR over the 12 months through Jul 31, 2026, up 42.0% from the prior 12 months. That is less than 1% of its revenue. Department of Veterans Affairs was the top awarding agency with 85.1% of obligations across 3 agencies.

    Federal Obligations

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated.

    Obligations
    $29.09M
    Change
    +42.0%
    Obligations to revenue
    0.1%
    Prior 12 months$20.49M
    Contracts with activity78
    New contracts50
    Top agencyDepartment of Veterans Affairs
    Top agency share85.1%
    Agencies3
    Average remaining term3.2 months

    12 months through Jul 31, 2026

    Largest New Awards

    The 10 largest new awards total $30.17M, and the largest makes up 15.7% of that.

    Award IDAgencyRecipientAmountStartEndDescription
    36C24826F0082Department of Veterans Affairs, Department of Veterans AffairsNOVARTIS PHARMACEUTICALS CORPORATION$4.73MFeb 24, 2026Aug 31, 2026PLUVICTO
    36C25726N0205Department of Veterans Affairs, Department of Veterans AffairsNOVARTIS PHARMACEUTICALS CORPORATION$4.16MFeb 7, 2026Feb 6, 2027LU177 - PLUVICTO/LUTATHERA
    36C26126F0007Department of Veterans Affairs, Department of Veterans AffairsNOVARTIS PHARMACEUTICALS CORPORATION$3.99MOct 1, 2025Sep 30, 2026PLUVICTO DRUG
    36C26226N0112Department of Veterans Affairs, Department of Veterans AffairsNOVARTIS PHARMACEUTICALS CORPORATION$3.91MNov 1, 2025Oct 31, 2026PLUVICTO AND LUTATHERA
    W81K0025FA195Department of Defense, Department of the ArmyNOVARTIS PHARMACEUTICALS CORPORATION$3.23MOct 1, 2025Sep 30, 2026LUTATHERA AND PLUVICTO
    36C24926N0263Department of Veterans Affairs, Department of Veterans AffairsADVANCED ACCELERATOR APPLICATIONS USA INC$2.91MDec 20, 2025Sep 30, 2026VISN PADIOPHARMACEUTICAL PLUVICTO DRUG
    36C25026N0310Department of Veterans Affairs, Department of Veterans AffairsNOVARTIS PHARMACEUTICALS CORPORATION$2.42MFeb 1, 2026Dec 31, 2026RADIOPHARMACEUTICALS PLUVICTO / LUTATHERA
    36C24426F0063Department of Veterans Affairs, Department of Veterans AffairsNOVARTIS PHARMACEUTICALS CORPORATION$1.98MJan 1, 2026Dec 31, 2026RADIOPHARMACEUTICALS-LUTATHERA AND PLUVICTO INJECTIONS
    36C26126F0017Department of Veterans Affairs, Department of Veterans AffairsNOVARTIS PHARMACEUTICALS CORPORATION$1.63MOct 1, 2025Sep 30, 2026PLUVICTO FY26
    36C25526N0132Department of Veterans Affairs, Department of Veterans AffairsADVANCED ACCELERATOR APPLICATIONS USA INC$1.20MFeb 17, 2026Feb 16, 2027PLUVICTO AND LUTATHERA
    New federal contracts awarded in the 12 months through Jul 31, 2026, largest first.

    Monthly Obligations

    The latest complete month, Apr 2026, had net de-obligations of $1.12M. The largest month in the table was Oct 2024, at $17.99M.

    MonthObligations
    Jul 2026-$2.08M
    Jun 2026-$1.01M
    May 2026$360,010
    Apr 2026-$1.12M
    Mar 2026-$998,364
    Feb 2026$12.22M
    Jan 2026$2.02M
    Dec 2025$10.85M
    Nov 2025-$206,449
    Oct 2025$7.81M
    Sep 2025$735,492
    Aug 2025$518,788
    MonthObligations
    Jul 2025-$1.71M
    Jun 2025-$2.19M
    May 2025-$1.04M
    Apr 2025-$2.21M
    Mar 2025-$1.95M
    Feb 2025$4.61M
    Jan 2025-$384,691
    Dec 2024$5.54M
    Nov 2024$4.68M
    Oct 2024$17.99M
    Sep 2024-$4.44M
    Aug 2024$1.59M

    Net obligations recorded each month, newest first. Agencies report contract actions with a delay (the Defense Department about 90 days), so the latest months, May to Jul 2026, are still incomplete and the 12-month total usually rises as agencies report the rest.

    Frequently Asked Questions About NVS

    How much does Novartis AG ADR receive in federal contracts?

    Novartis AG ADR had $29.09M in federal contract obligations over the 12 months through Jul 31, 2026, compared with $20.49M in the 12 months before, up 42.0%. Obligations are contract bookings by the awarding agency, not recognized revenue.

    What are Novartis AG ADR's largest government contracts?

    The largest new awards over the 12 months through Jul 31, 2026 were 36C24826F0082, Department of Veterans Affairs, $4.73M, started Feb 24, 2026; 36C25726N0205, Department of Veterans Affairs, $4.16M, started Feb 7, 2026; 36C26126F0007, Department of Veterans Affairs, $3.99M, started Oct 1, 2025.

    Which agencies award Novartis AG ADR contracts?

    Department of Veterans Affairs was the top awarding agency with 85.1% of obligations over the 12 months through Jul 31, 2026. The records cover 3 agencies. Other agencies in the awards list include Department of Defense.

    What new federal contracts did Novartis AG ADR win in the 12 months through Jul 31, 2026?

    Novartis AG ADR won 50 new federal contracts in the 12 months through Jul 31, 2026. The largest was 36C24826F0082, Department of Veterans Affairs, $4.73M, started Feb 24, 2026.

    How do Novartis AG ADR's federal obligations compare with its revenue?

    Federal contract obligations were $29.09M over the 12 months through Jul 31, 2026, equivalent to less than 1% of Novartis AG ADR's revenue. Obligations are amounts the government committed to contracts in the period, not the share of Novartis AG ADR's revenue that comes from the government.